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Abstract
Background: Leprosy was common in Europe eight to twelve centuries ago but molecular confirmation of this has been
lacking. We have extracted M. leprae ancient DNA (aDNA) from medieval bones and single nucleotide polymorphism (SNP)
typed the DNA, this provides insight into the pattern of leprosy transmission in Europe and may assist in the understanding
of M. leprae evolution.
Methods and Findings: Skeletons have been exhumed from 3 European countries (the United Kingdom, Denmark and
Croatia) and are dated around the medieval period (476 to 1350 A.D.). we tested for the presence of 3 previously identified
single nucleotide polymorphisms (SNPs) in 10 aDNA extractions. M. leprae aDNA was extracted from 6 of the 10 bone
samples. SNP analysis of these 6 extractions were compared to previously analysed European SNP data using the same PCR
assays and were found to be the same. Testing for the presence of SNPs in M. leprae DNA extracted from ancient bone
samples is a novel approach to analysing European M. leprae DNA and the findings concur with the previously published
data that European M. leprae strains fall in to one group (SNP group 3).
Conclusions: These findings support the suggestion that the M. leprae genome is extremely stable and show that
archaeological M. leprae DNA can be analysed to gain detailed information about the genotypic make-up of European
leprosy, which may assist in the understanding of leprosy transmission worldwide.
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Introduction
Leprosy remains a public health problem with over 210,000
registered cases worldwide at the beginning of 2008. Mycobacterium
leprae (M. leprae), is an obligate intracellular parasite and has proved
to be uncultivable on artificial medium only growing in susceptible
animal models such as the foot pads of mice [1] and the nine
banded armadillo [2].
Leprosy is thought to have been brought to Britain by Roman
armies that had been based in Asia and the Middle East
previously. The prevalence of leprosy increased in Europe after
1000 A. D. and increased up until the 14–15
th Century A. D.
when a rapid decline was observed, the cause of this is unknown.
Leprosy remained in Scandinavia until the 16
th century when it
disappeared mostly, only remaining in Norway [3]. The last case
of leprosy in Norway was registered in 1953 [4]. Today, the
majority of European leprosy cases are considered to be imported
from leprosy endemic countries [5].
The obligate intracellular status of M. leprae is probably due to the
extreme reduction of the genome, at 3.3 Mb it has lost almost 2,000
genes in comparison to Mycobacterium tuberculosis[6]. Less than half of
the M. leprae genome contains functional genes and gene deletion
and decay appears to have eliminated many important metabolic
activities, including part of the oxidative and most of the
microaerophilic and anaerobic respiratory chains [7]. Clinical
leprosy presents with a spectrum of features ranging from localised
tuberculoid disease to widespread lepromatous disease. If left
untreated, the mycobacterium can directly invade the skeleton of its
host, giving rise to characteristic destructive leprous osteomyelitis
lesions that can be identified long after the death of the individual
[8]. Bone changes are most frequently identified in the hands and
feet of leprosy patients, other lesions include localised osteoporosis,
honeycombing and concentric bone absorption [9].
The principle method of pathogen DNA survival within an
archaeological specimen is unknown. Very little is known about
the levels of pathogen DNA preserved in bone and the ability of
this pathogen to survive in bone following the death of the host.
Most pathogens are at a particular disadvantage as they do not
invade the bone structure and have a weak cell wall. M. leprae in
comparison, is known to invade the macrophages of the host and
has a thick, waxy, mycolic acid coating. It has been suggested that
this component has a protective role, enhancing the survival of
Mycobacterial DNA in archaeological samples [10,11].
The first isolation of mycobacterial DNA from archaeological
samples was by Spigelman et al in 1993 [12], who developed a
technique using PCR amplification to identify degraded, genetic
material in ancient bone samples. The publication detailed PCR
protocols, bone preparation and the findings from several pilot
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from ancient bone samples [12]. This technique was used to
isolate, M. tuberculosis DNA from lung lesions (N1 and N2) of a
spontaneously mummified, 1000-year-old adult female body in
southern Peru, using the amplification of a 123 bp segment of the
IS6110 element specific to M. tuberculosis. Following this work,
several researchers published work on the presence of M.
tuberculosis DNA in archaeological material including bone [13],
calcified pleura [14] and mummified remains [15].
In 1994, M. leprae DNA was successfully isolated from ancient
human bone samples over 1000 years old and PCR assay confirmed
the presence of an M. leprae specific segment of DNA sequence
(RLEP) [16]. Later, Haas et al [17] extracted M. leprae specific DNA
fragments (RLEP1 and RLEP3) from skeletal remains exhumed
from a South German ossuary and a Hungarian cemetery.
More recently, the analysis of M. leprae aDNA extracted from
archaeological material became more detailed with the inclusion
of variable nucleotide tandem repeat (VNTR) analysis [18].
Following this work, Monot et al [19] compared the stability of two
different markers of genomic biodiversity of M. leprae in several
biopsy samples isolated from the same leprosy patient (VNTRs
and SNPs). The group observed no variation in the SNP profiles
but considerable variation in the VNTR profiles, suggesting that
VNTR analysis may be too dynamic for use as epidemiological
markers for leprosy. The identification of SNPs in the modern M.
leprae genome has only been completed recently [19]. It is thought
that the identification of these SNPs in pathogenic bacteria may
assist in the understanding of important factors, such as disease
susceptibility, the location of real locus involved in disease
development and the epidemiology of the bacteria [19].
The present report describes the molecular methods used to test
for the presence of 3 previously published SNPs in M. leprae DNA
extracted from ancient European skeletal remains. The methods,
termed SNP typing include PCR amplification and sequencing of
areas of the M. leprae genome known to contain SNPs of interest
that have been previously described [19]. The PCR assays have
been applied to aDNA extracted from skeletons exhumed in 3
European countries with the aim of comparing these findings to
SNP data already available for world-wide modern M. leprae DNA.
Materials and Methods
Ethical approval to work with ancient human material was
obtained for all sample sites and also from the ethics committee at
the London School of Hygiene and Tropical Medicine
(LSHTM). For the UK samples, ethical approval was given by
Cambridgeshire County Council, Archaeological Field Unit and
the English Heritage, Centre for Archaeology, Portsmouth. For
samples collected in Copenhagen, approval was granted by the
Medical History Museum and in Odense, Denmark, approval
was gained through Odense University ethics committee. For the
remaining locations, ethical approval was granted during
excavation by the governing body responsible for the skeletal
material and burial site.
10 bone samples were collected from skeletons exhumed from
the UK (Norwich) and Europe (Denmark and Croatia) (Table 1).
Samples were selected at random from the European archaeolog-
ical bone collection at LSHTM and all samples in the collection
were taken from a site on the skeleton most likely to have been
invaded by M. leprae including the rhino-maxillary area and hand
and foot bones [20]. All the skeletons showed typical signs of
leprous osteomylitis, including resorption of the anterior nasal
spine, rounding and widening of the nasal aperture, erosion of the
alveolar margin and pitting of the hard palate. The long bones
showed deposits of woven bone and the hands and feet showed
honeycombing and concentric bone absorption. Bone samples
were stored at minus 20 degrees centigrade until analysis.
Skeletons used for teaching purposes or for museum displays,
were sampled sparingly from the rhino-maxillary area or an area
that would not damage the appearance of the bones. Skeletal
samples were either sampled on site by the author, or a protocol
was sent to the curator of the collection who would sample the
material.
In some cases, curators preferred to sample the skeletons or
access was not possible. For these cases, a protocol was designed to
allow curators of bone collections to sample the material effectively
and safely without the presence of the author. Briefly, this protocol
included requesting the sampler to wear gloves for each sample,
use a sterile scalpel blade and sample on a disposable surface such
as paper towel or a clean sheet of A4 paper. The sampler was
requested to collect around 100 mg (0.1 gram) of bone from an
area most likely to have experienced direct bacterial invasion
including the rhino-maxillary area, hands, feet and nasal bones.
The long bones (Leg bones) of the skeleton are also a possible
source where typical lepromatous changes had occurred. Each
sample was stored in a sterile tube and transported back to the lab
with the related log sheet providing as much information as
possible about the samples.
Table 1. Skeleton sample information, location, period and burial dates.
Country Sample reference Skeletal sample site Burial Location Period Number of samples
Croatia 1A Rhino-maxillary Radasinovci 8
th–9
th Century AD 4
2A
3A
4A
Denmark G483 Palatine Odense Leprosarium 1275–1560 AD 1
UK 11784 Rhino-maxillary St. John’s Timberhill,
Norwich
900–1000 AD 5
11287 5
th metatarsal
11503 Tibia lesion
11287 5
th metatarsal
11428 Rhino Max
doi:10.1371/journal.pone.0007547.t001
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padded envelope and transported to the London School of
Hygiene and Tropical Medicine via the postal service or a courier
selected by the curator. The samples were kept as cool as possible
during the journey.
Each skeleton was examined paleopathologically by the curator
of the collection and the sex, approximate age, burial date and
excavation location were recorded along with any skeletal lesions.
The sex of the skeleton was ascertained using pelvic and skull
comparison measurement techniques. Radio carbon dating was
carried out where possible, when not possible, the burial date was
estimated from other artefacts buried with the skeletons and the
location and position of the site. A log sheet was filled in for each
sample taken and the curator was requested to provide any
literature available about the burial site and skeletons sampled.
The bones included in this study have been stored in separate,
sealed containers following extraction and were cleaned by the
related institutions following their own protocols. All the reagents
are specifically dedicated to aDNA extraction and are stored
separately from other extraction reagents in the lab. Protective
sterile gloves were worn during the extraction, which was carried
out on a dedicated bench using sterile tools, tubes and disposable
bench coat (changes after every extraction. The bench was cleaned
with DNAse away (Molecular Bioproduct, San Diego, CA) before
and after every aDNA extraction and reusable equipment such as
the pestle and mortars were autoclaved before use and lab coats
were clean. Since we were not working with human DNA, the use
of protective clothing such as masks and booties was considered
unnecessary. Only 1 set of aDNA extractions were completed each
week and the lab was cleaned thoroughly before commencing the
next extraction. At the time of aDNA extraction, the laboratory
worked only with aDNA and one modern Indian M. leprae isolate.
In the laboratory, samples were weighed and then ground down to
a fine powder in a sterile pestle and mortar on a clean bench. A
modified version of the protocol used by Bouwman and Brown
[21] was used for aDNA extraction. Briefly, the bone powder was
placed into a 15 ml tube and 1 ml of extraction buffer (0.5 M
EDTA pH 8, 0.5% Tris, 100 mg/ml-1 proteinase K) (Nuclisens,
Biomerieux) was added to each tube including an empty tube to be
used as an extraction blank control. The tube was incubated at
55uC for 24 hours and then underwent three freeze-thaw cycles in
liquid nitrogen. Once fully defrosted the samples were centrifuged
at 2000 rpm for 5 minutes. The supernatant was transferred to a
new 15 ml tube containing 2.5 ml PB buffer (QIAGEN, West
Sussex) and mixed gently. 0.75 ml of this solution was added onto
a QIAquick column and centrifuged at 14,000 rpm for 1 min. The
buffer collected in the external tube was discarded. This step was
repeated until all the solution had been passed through the
column. 0.75 ml PE buffer (QIAGEN, West Sussex) was added to
each column. Following centrifugation at 14,000 rpm for 1
minute, the buffer was discarded and the internal section of the
column was transferred into clean tubes. 50 ml of extraction buffer
(QIAGEN, West Sussex) was added to the centre of each column
and incubated for 1 minute. The columns were centrifuged at
14,000 rpm for 1 minute and the eluate collected in a fresh 0.5 ml
non-stick Eppendorf tube. The extract was stored at 280uC until
analysis. Independent confirmation was provided by a second
member of the laboratory in a different laboratory in a separate
area of the institution. aDNA was extracted from bone sample
G483 (Denmark) and amplified by to confirm result. The precious
nature of the bone meant that duplication could not be carried out
on all of the archaeological specimens.
The 3 previously published SNP assays [19] were used to
identify SNPs in the ancient DNA extractions. However, any DNA
persisting in old archival material is more likely to be damaged
than that from more modern samples so PCR primers were
designed to amplify smaller amplicons. All primers were calculated
using the published M. leprae sequence [22] and checked using a
Basic Local Alignment search tool (http://www.ncbi.nlm.nih.gov/
BLAST/). Each primer was designed to be around 18–27 bp in
length, have a Tm of around 64–70uC and have a G+C content
lower than 50%. The RLEP (repetitive element) multi-copy target,
specific to M. leprae, was used for initial screening of samples, to
determine the presence of M. leprae DNA (Table 2). Primers for
this were designed from the published RLEP primers [23]. SNP
Primers can be viewed in Table 3 along with key PCR conditions
and product sizes.
The DNA standard used as a positive control in the study
consisted of 5 mg of DNA. This DNA was a modern isolate
passaged through the armadillo, strain 4089, batch NAG 8.4.03C,
supplied by Patrick Brennan through the NIH leprosy contract
(http://www.cvmbs.consolate.edu/mip/leprosy/index.html). 5 ml
of the stock solution was diluted in 100 ml of nuclease free water
(Qiagen) and aliquoted into 5 tubes, each containing 21 ml of the
diluted stock solution. The positive control DNA cannot be
distinguished from the European aDNA when amplified using the
RLEP primers used in the initial analysis, however, the control M.
leprae DNA is most similar to the Tamil Nadu published sequence
of M. leprae (it is a modern Indian isolate) and, therefore, belongs to
group 4, showing a difference at all of the 3 SNP points used in the
study, detecting contamination. The positive controls were run
separately from the samples to reduce the risk of DNA transfer
within the PCR machine and the DNA was only removed from
the machine and added to the gel after all samples had been
loaded.
All PCR assays included 2 negative controls which contained
the PCR reaction mix and Nuclease free water (Qiagen). These
were loaded before and after the M. leprae standard during the
PCR amplification and electrophoresis to avoid cross-contamina-
tion via the tube or well. Cycling conditions for both the standards
and the negative controls were kept the same as the sample
conditions and the annealing temperature was determined by
optimisation of the primer set.
All PCR reagents used in the study were dedicated for aDNA
analysis and stored separately from other reagents. All PCR set up
was carried out in a PCR workbench and UV light was used to
decontaminate the area before and after any work. PCR assays
were performed using the GeneAmp H 2700 PCR system (Applied
Biosystems, Cheshire, UK). The Horizon 11.14 tank (Invitrogen,
Paisley, Scotland) was used for gel electrophoresis to check purity
and DNA concentration of PCR products. PCR products were
purified using the QIAquick PCR Purification Kit (Qiagen)
according to manufacturer’s instructions. 5 volumes of PB buffer
(supplied in kit) were added to 1 volume of the PCR product and
Table 2. RLEP primer sequences, melting temperatures,
binding positions on DNA and NCBI accession numbers.
Primer Sequence
a TmuC
Accession
number
Amplicon
size
RLEP F2 F 59-CATTTCTGCC-
GCTGGTAT-39
56.9 AL583917.1 111 bp
RLEP R4 R 59-ATCATCGATG-
CACTGTTCAC-39
56.6
aF, forward; R, reverse.
doi:10.1371/journal.pone.0007547.t002
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tube. The column was centrifuged for 60 seconds to bind the
DNA. The supernatant was discarded and the column washed in
0.75 ml PE buffer. To elute the DNA, 20 ml EB buffer was added
to the centre of each column and incubated for 1 minute. The
column was then centrifuged for 1 minute and the supernatant was
collected. Cycle sequencing of the purified PCR products was
carried out using the ABI BigDye v3.0 Cycle Sequencing Ready
Reaction Kit (Applied Biosystems, Cheshire, UK) according to the
manufacturers recommendations and the GeneAmp H 2700 PCR
system (Applied Biosystems, Cheshire, UK). Cycling conditions
differed to the manufacturer’s instructions and were as follows:
96uC for 30 seconds and 25 cycles of 96uC for 30 seconds, 50uC
for 15 seconds and 60uC for 4 minutes.
Following cycle sequencing, the reactions were passed through
the DyeEx 2.0 spin column kit (Qiagen) for dye terminator removal
according to the manufacturer’s instructions. Briefly, the product
was loaded into the centre of the spin column and centrifuged for 3
minutes at low speed. The supernatant was then collected in a
1.5 ml no stick Micro tube (Alpha laboratories, Hampshire, UK)
and freeze dried. Following re-suspension in formamide, the
samples were analysed using the ABI3730 genetic analyzer (Applied
Biosystems). Sequences were imported and analysed in the ABI
sequence scanner V1.0 software downloaded from the Applied
Biosystems website (http://www.appliedbiosystems.com/). All se-
quenceswerecomparedtothoseheldintheNCBIdatabase(http://
www.ncbi.nlm.gov) using BLAST (Basic Local Alignment Search
Tool) to find regions of local similarity.
Results
The aDNA was confirmed as being from M. leprae by identifying
the RLEP repetitive sequence using specially designed primers
(primers 2 & 4) amplifying a 111 bp product. The RLEP repetitive
sequence was detected in 3 samples from the United Kingdom
(11784, 11287 and 11503), one sample from Denmark (G483) and
2 samples from Croatia (2A and 3A). This aDNA was sequenced
in duplicate, using the QIAGEN Dye-ex column system and
checked by BLAST search. Figure 1 shows an example of the
electrophoresis gel. The remaining 4 DNA extractions (1A, 4A,
11287 and 11428) were negative for M. leprae DNA and were not
analysed further.
On SNP typing, a ‘C’ was found at SNP 14676 in M. leprae
aDNA extracted from 6 DNA extractions from bone exhumed in
the UK, Croatia and Denmark that contained the RLEP
sequence. PCR amplicons were visualised on 3% agarose and a
band of expected 131 bp size was seen following electrophoresis,
the amplicons were then sequenced. All sequence data was
confirmed using BLAST search and the results were duplicated to
ensure accuracy. Figure 2 shows an example of the sequence data
for SNP 14676. The sequence was also checked for differences in
positions other than at the point of SNP mutation, no differences
were observed.
On SNP typing, a ‘C’ was found at SNP 2935685 in the M.
leprae aDNA extracted from the 6 skeletal remains samples
included in the SNP identification from the UK, Croatia and
Denmark. The aDNA extractions were amplified by PCR using
the SNP2935685 assay. Visualisation on 3% agarose confirmed a
positive result and following sequencing (Figure 3), the data was
checked using BLAST search and duplicated for accuracy. Figure 4
shows an example of the sequence data for SNP 2935685.
On SNP typing, a ‘T’ was found at SNP location 1642875 in the
genome of aDNA extracted from all 6 skeletal remains samples
from the UK, Croatia and Denmark. The aDNA was amplified by
PCR using the SNP1642875 assay. Visualisation on 3% agarose
confirmed a positive result and following sequencing, the data was
checked using BLAST search and duplicated for accuracy.
Previously, the 3 SNP PCR assays (SNP14676, SNP1642875
and SNP2935685), were used to group 175 modern M. leprae
isolates from 21 countries into 4 SNP types [19]. Europe was
included in this study and consisted of 2 M. leprae isolates of French
origin. Using this SNP typing method, The 6 aDNA isolates
included in this study fall into SNP-type 3.
Discussion
Evolutionary analysis of bacteria to address questions of
biogeography are really limited and have mostly been done
relatively recently. This study provides European archaeological
M. leprae SNP data and is a novel approach to analysing the
Figure 1. 3% agarose gel showing clear bands for the aDNA
extracts taken from sample G483, 2A and 3A, matching the
size of the M. leprae positive control DNA following amplifica-
tion with RLEP primers 2 & 4 (111 bp), Croatian samples 1A
and 4A did not show a matching band and were not analysed
further. Key: 1. M. lep pos control DNA. 2. 2A (Croatia). 3. 3A (Croatia). 4.
4A (Croatia). 5. 1A (Croatia). 6. Extraction blank 1. 7. Extraction blank 2. 8.
Water control 1. 9. Water control 2 (run with positive control). 10. G483
(Denmark). 11. 100 bp ladder. N.B. The M. leprae positive control
DNA (lane 1) was amplified separately from the extractions to
avoid contamination.
doi:10.1371/journal.pone.0007547.g001
Table 3. SNP primer sequences, melting points (Tm), binding positions on DNA and NCBI accession numbers.
Primer set name Primer Sequence Tm uC
SNP location on
genome
NCBI Accession
number Product size (bp)
SNP14676 F2 59-ACGAATTCGTTGAACAGTCTC-39 59.47 14676 AL583917.1 131
R5 9-CAATGCATGCTAGCCTTAATGATAAA-39 60.09
SNP2935685 F2 59-CTCGGAGAATTTCTATGCAAGTTTGA-39 61.66 2935685 AL583925.1 151
R5 9-ACCGGTGAGCGCACTAAG-39 62.95
SNP1642875 F2 59-GGCTCGTCACAAATCCGAGTTT-39 63.4 1642875 AL583921.1 115
R5 9-GTAGTAGTCTTCCAAGTTGTGGTG-39 63.69
doi:10.1371/journal.pone.0007547.t003
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leprae DNA from 6 skeletons that are eight to twelve centuries old
and obtained from widely separated geographical locations in
Europe (UK, Denmark and Croatia). Previous molecular analysis
of ancient M. leprae DNA has not included SNP analysis and
European samples included in the previously published SNP
research [19] relied on 2 undated biopsy samples, thought to be
under 100 years old and of unclear provenance. Analysis of the M.
leprae aDNA genome using SNP identification, included in this
project, has provided a unique and insightful way of analysing
skeletal remains.
Monot et al [19] published work identifying 3 SNP locations in
the modern M. leprae genome that could be used to identify 4 SNP
types, with the two M. leprae strains from France being SNP type 3.
The data of this paper indicates that M. leprae has an extremely
stable genome and that SNPs can be identified in modern clinical
material that begin to provide a map of leprosy transmission
worldwide. The decline of leprosy cases in European countries
means that no modern material can be sourced for this SNP
identification technique with any certainty that the strain is of
European origin. SNPs in M. leprae aDNA extracted from skeletal
remains from 3 European countries (Denmark, Croatia and the
United Kingdom) have been successfully identified in this study,
with the findings indicating that European leprosy isolates form
SNP-type 3, as was previously suggested [19].
The findings of Monot et al [19], suggest that all cases of leprosy
could be attributed to a single clone, with the dissemination of this
clone being traceable, using SNPs to suggest that leprosy originated
in Africa and spread by human migration. The group showed that
the M. leprae strain responsible for leprosy in the European and
North African countries was most similar to the strain responsible
for most disease in the Americas and suggested that colonialism and
emigration from the old world may have contributed to the
introduction of leprosy into the new world. The findings from this
study agree with the previously suggested transmission pattern and
haveworkedtowards being able to provide European SNPresults in
addition to the world-wide findings of the transmission map created
at the Institut Pasteur [19].
The presence of M. leprae DNA in long bones, hands and feet of a
skeleton is unusual but not overly surprising. Research into M.
tuberculosis DNAanalysisinarchaeological specimens has shown that
whilst the aDNA comes from a skeleton showing typical lesions, the
sample of bone did not need to come from an area close to a lesion
[24,25], implyingthat thelocation ofsampling maynot be critical as
the pathogen DNA was present in the blood stream, a theory
proposed by Barnes and Thomas [26]. Periostitis with subperiosteal
new bone deposits is not uncommon in the long bones of
lepromatous leprosy patients [27]. Although it is not clear if this
long bone damage is always due to direct M. leprae invasion, it is
knownthat wherevertheM.leprae aredepositedbythe macrophage,
the bacilli colonise the locality, grow and produce lesions. A study
on M. lepraemurium infected mice found that 3–5% of the mice
showedbilateralparalysisoftherearlimbs.Followingdissection and
within the bones the bone marrowwas replaced by extended bacilli-
laden granulomas that frequently eroded the bone wall [28].
Contamination of aDNA extractions is a major concern in this
type of work and (especially for human aDNA extraction
contaminated with modern human DNA) is a common problem
for ancient DNA analysis. The rigorous methodology of Cooper &
Poinar [29] to avoid modern or ancient DNA contamination must
be considered and adhered to as much as possible, however, when
looking at bacterial aDNA, one must put the environmental
situation into context. aDNA extraction for the purpose of this study
was carried out in a laboratory that has worked with modern Indian
M. leprae DNA in the past and uses the DNA of a modern Indian M.
leprae isolate as a positive control. The laboratory never receives
European M. leprae DNA that could contaminate the ancient
samples and the lack of genuine M. leprae isolates originating in
European countries currently would make this a difficult process.
The results were duplicated in a laboratory that does not work with
M. leprae DNA, strengthening the probability that the results did not
stem from contamination and although duplication of results in a
Figure 2. Sequence of SNP 14676 showing a ‘‘C’’ (highlighted in yellow) for aDNA extracted from St John’s Timber Hill skeletal
sample 11784 (rhino-max).
doi:10.1371/journal.pone.0007547.g002
Figure 3. 3% agarose gel stained with ethidium bromide visualising the reproduction of amplification of aDNA extraction from
skeletal UK samples 11784, 11287 and 11503, following amplification with SNP-2935685 (151 bp). 1. Sample 11784. 2. Blank well. 3.
Sample 11287. 4. Blank well. 5. Sample 11503. 6. Extraction blank. 7. M. leprae control DNA. 8. Negative water control. 9. 100 bp ladder.
doi:10.1371/journal.pone.0007547.g003
SNP Analysis of M. leprae DNA
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probability, it should not be considered fundamental.
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